PTEN and cancer: Downstream activation of PI3K pathway effectors in cancer are the foremost hallmarks of PTEN loss; however, PTEN loss has also been demonstrated to activate a plethora of pathways including Ras–MAPK, Wnt/β-catenin, Notch, and Hippo pathways through PIP3-dependent signals3–7.